Review
doi: 10.3109/00016347609156449.
Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives
- PMID: 788446
- DOI: 10.3109/00016347609156449
Item in Clipboard
Review
Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives
Acta Obstet Gynecol Scand Suppl.
1976.
No abstract available
Similar articles
-
Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.Acta Obstet Gynecol Scand Suppl. 1976;54:67-70. doi: 10.3109/00016347609156451. Acta Obstet Gynecol Scand Suppl. 1976. PMID: 788448 Clinical Trial.
-
Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.Acta Obstet Gynecol Scand Suppl. 1979;88:43-8. doi: 10.3109/00016347909157228. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 393049 Clinical Trial. No abstract available.
-
[Use of Ovidon, Rigevidon and Postinor for contraception].Akush Ginekol (Mosk). 1983 Nov;(11):22-4. Akush Ginekol (Mosk). 1983. PMID: 6666791 Russian. No abstract available.
-
Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1556-61. doi: 10.1016/s0002-9378(94)05019-2. Am J Obstet Gynecol. 1994. PMID: 8178906 Review.
-
[Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].Adv Contracept. 1994 Jul;10 Suppl 1:41-9. Adv Contracept. 1994. PMID: 7839871 Review. Spanish. No abstract available.